Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by PrettyPennieson Jun 16, 2018 5:44pm

87 Views

Post# 28182118

PDT for superbugs?

It has been a while, but I seem to remember that Theralase once indicated that PDT might be use for superbugs, like antibiotic resistant staph, etc. I am not sure if this was being investigated for patients or for instruments/surgical areas, etc or both. I haven’t seen anything for a long time about this— is this still being researched?

Bullboard Posts

A potential breakthrough in spinal cord and optic nerve injury treatment